Tender Title: Supply of Drugs
Reference Number: GEM/2025/B/6164356
Issuing Authority
The Department of Atomic Energy is inviting bids for the procurement of various pharmaceutical products, aimed at enhancing healthcare provisions.
Scope of Work and Objectives
The objective of this tender is to secure a reliable supply of essential drugs, specifically focusing on:
- Hydrocortisone 100 mg Injection, packaged as 1x100 mg
- Metronidazole Tablets 400 mg, packaged as 1x15 tablets
- Furosemide Injection (10 mg per ml), packaged as 1x4 ml
The total quantity required is 31,200 units across the aforementioned products. Both quality and timely delivery of these pharmaceuticals are essential to meet healthcare standards.
Eligibility Criteria
To qualify for this tender, bidders must meet the following requirements:
- Must be a registered pharmaceutical company or supplier.
- Demonstrate capability to deliver the specified quantities within the timeline.
- Must comply with local and international regulations pertaining to pharmaceutical supplies.
Technical Requirements
Bidders are expected to provide:
- Certification of product quality that meets regulatory standards.
- Documentation of adherence to GMP (Good Manufacturing Practices).
- Complete product specifications and laboratory test results confirming compliance with quality standards.
Financial Requirements
- Bidders must provide their financial capabilities including:
- Latest audited financial statements.
- Pricing details for each of the drugs mentioned.
- Any applicable taxes and duties.
Document Submission Details
Interested suppliers must submit their proposals through the e-procurement platform. All necessary documents supporting technical and financial capabilities should be included.
Special Provisions
There are provisions to support Micro, Small, and Medium Enterprises (MSEs) and startups. Such entities are encouraged to participate and may be given preference in the evaluation process.
Evaluation Process
Bids will be evaluated based on:
- Compliance with technical specifications and quality standards.
- Financial viability and pricing competitiveness.
- Reliable delivery timelines and past performance in similar tenders.
Delivery Locations
Successful bidders will be required to deliver to designated locations as specified by the Department of Atomic Energy post-evaluation.
Contact Information
For any queries regarding this tender, interested bidders may reach out to the official contact points provided on the tender portal.
This tender presents a vital opportunity for suppliers in the pharmaceutical industry to partner with government efforts in improving healthcare infrastructure. Complying with eligibility and submission requirements will enhance the chances of a successful bid.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
7 DocumentsSimilar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered pharmaceutical supplier, having the necessary licenses to operate, and demonstrating the capability to supply the specified quantity of drugs within the stipulated timelines. Bidders must comply with local regulations and may also need to provide references from previous contracts undertaken.
Bidders must provide documentation including quality certificates that comply with Good Manufacturing Practices (GMP) and any relevant regulatory certifications applicable to pharmaceutical supplies. Additionally, bidders may need to submit test reports confirming the quality and efficacy of the products offered.
The registration process involves creating an account on the e-procurement platform designated for this tender. Once registered, bidders must upload the necessary documentation along with their bid proposals. Detailed steps should be outlined in the procurement portal’s user guide for participants.
The Earnest Money Deposit (EMD) amount and submission details will be outlined within the tender documents. This deposit acts as a security measure and is typically mandatory for participating in the bid. Participants should ensure compliance with EMD requirements to avoid disqualification.
Yes, provisions exist for Micro, Small, and Medium Enterprises (MSEs); these businesses may receive preferential treatment during the evaluation process. This may include relaxed eligibility requirements or additional points in the evaluation score, thereby aiding in promoting local entrepreneurship and incentivizing participation in government procurement.
This set of FAQs aims to guide potential bidders in understanding the tender process and enhance their chances of compliance and successful submission.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders